Mydecine Innovations Group (NVRS) Ownership - Who Owns Mydecine Innovations Group?
Mydecine Innovations Group (NVRS) Ownership Overview
- 1.96% Insiders
- <0.01% Other Institutional Investors
- 98.04% Public Companies and Individual Investors
The ownership structure of Mydecine Innovations Group (TSE:NVRS) stock is a mix of institutional, retail, and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 1.96% is owned by Insiders, and 98.04% is owned by Public Companies and Individual Investors.
The ownership structure of Mydecine Innovations Group (TSE:NVRS) stock is a mix of institutional, retail, and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 1.96% is owned by Insiders, and 98.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Empel Ray Van | 1,116,505 | Insider | 1.91% | 35,728 |
| David Joshua Bartch | 29,519 | Insider | 0.05% | 945 |
FAQ
Who Owns Mydecine Innovations Group (TSE:NVRS)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 1.96% is held by insiders, and 98.04% is held by public companies and individual investors.
What percentage of Mydecine Innovations Group (TSE:NVRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Mydecine Innovations Group (TSE:NVRS) stock is held by institutional investors.
What percentage of Mydecine Innovations Group (TSE:NVRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.04% of Mydecine Innovations Group (TSE:NVRS) stock is held by public companies and individual investors.
Who owns the most shares of Mydecine Innovations Group (TSE:NVRS)?
Empel Ray Van owns the most shares of Mydecine Innovations Group (TSE:NVRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
